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Never or curtailed lactation has been associated with an increased risk for incident hypertension, but the effect
of exclusive breastfeeding is unknown. The authors conducted an observational cohort study of 55,636 parous
women in the US Nurses’ Health Study II. From 1991 to 2005, participants reported 8,861 cases of incident
hypertension during 660,880 person-years of follow-up. Never or curtailed lactation was associated with an
increased risk of incident hypertension. Compared with women who breastfed their first child for 12 months,
women who did not breastfeed were more likely to develop hypertension (hazard ratio (HR) ¼ 1.27, 95% confidence
interval (CI): 1.18, 1.36), adjusting for family history and lifestyle covariates. Women who never breastfed
were more likely to develop hypertension than women who exclusively breastfed their first child for 6 months
(HR ¼ 1.29, 95% CI: 1.20, 1.40). The authors found similar results for women who had never breastfed compared
with those who had breastfed each child for an average of 12 months (HR ¼ 1.22, 95% CI: 1.13, 1.32). In
conclusion, never or curtailed lactation was associated with an increased risk of incident maternal hypertension,
compared with the recommended 6 months of exclusive or 12 months of total lactation per child, in a large
cohort of parous women.
breast feeding; hypertension; lactation; oxytocin; parity; pregnancy; prolactin; women
Abbreviations: BMI, body mass index; CI, confidence interval; DASH, Dietary Approaches to Stop Hypertension; HR, hazard ratio;
IPW, inverse probability weight.
Primary prevention of hypertension is a major public
health priority. Although pharmacologic treatment can re-
duce the burden of this disease, compliance is poor, and
adverse effects of treatment are common (1). Thus, hyper-
tension remains a leading preventable cause of death for
women (2).
Multiple lifestyle factors have been associated with in-
creased incident hypertension (3). In addition, parous women
who never breastfed (4) or only briefly lactated (5) may also
have an increased risk of developing hypertension, compared
with women who lactate for longer periods of time. Absent
or premature discontinuation of lactation has also been asso-
ciated with increased risks for diabetes (5–8), hyperlipidemia
(5, 9), the metabolic syndrome (10, 11), and cardiovascular
disease (5, 12, 13).
The mechanisms underlying these associations are not
known. Lactation is associated with weight loss in some, but
not all, studies, and we have previously hypothesized that
lactation may ‘‘reset’’ maternal metabolism after pregnancy,
reducing risk of obesity-related disease (14). Lactation also
activates central neuroendocrine pathways, including oxytocin
and prolactin, and these hormones have been associated with
blood pressure regulation (15) and incident hypertension
risk (16).
However, unmeasured confounding is a major concern in
studies of lactation and health outcomes, because mothers
who breastfeed are more likely to engage in other health-
promoting behaviors (17, 18). Such confounding is a potential
limitation of the 3 prior studies that have measured the as-
sociation between lactation and hypertension. One study
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assessed incident disease in a population without data on
dietary intake other than alcohol (4), and 2 studies measured
prevalent hypertension, adjusting only for concurrent health
behaviors (5, 11). No prior study has included information on
pregnancy complications, such as preeclampsia or preterm
birth, which may affect both breastfeeding success and ma-
ternal hypertensive disease risk. Moreover, previous studies
have not considered the timing of introduction of foods
other than breast milk, which is a measure of breastfeeding
intensity.
To address these limitations in the existing literature, we
measured the association between duration and exclusivity
of lactation and incident maternal hypertension in the second
Nurses’ Health Study. This large, prospective cohort includes
data on duration of exclusive lactation for each child, as well
as hypertensive pregnancy complications and preterm birth.
Moreover, the study design allowed us to adjust our analyses
for multiple lifestyle factors previously associated with risk
of incident hypertension in women (3). We further conducted
a sensitivity analysis to quantify the degree of unmeasured
confounding that would explain observed associations between
lactation and incident hypertension.
MATERIALS AND METHODS
Study population
The Nurses’ Health Study II began in 1989, enrolling
116,608 women from 14 US states. Participants were between
25 and 42 years of age at baseline. Each woman completed
detailed questionnaires every 2 years. We limited the current
analyses to data collected since 1991, the first year for which
dietary data were available. We limited our analysis to women
who could be ‘‘exposed’’ to breastfeeding, by excluding
women who were nulliparous (n ¼ 22,590), as well as those
with missing data on breastfeeding (n ¼ 19,605). Compared
with women for whom breastfeeding data were available,
women missing data on breastfeeding were less likely to
self-identify as Caucasian (90% vs. 94%) or to be currently
using oral contraceptives (60% vs. 73%) and were more likely
to be current smokers (13% vs. 9%) and to be missing data on
other health behaviors. However, the 2 groups were similar in
age (assessed in 1991), year of first birth, body mass index
(BMI) at age 18 years, and family history of hypertension.
We further excluded women who reported a diagnosis of
hypertension prior to 1991 (n ¼ 4,583) or who in 1989 re-
ported elevated blood pressure (median systolic blood pres-
sure >120 mm Hg or diastolic blood pressure>80 mm Hg,
n ¼ 7,038) or antihypertensive medications (n ¼ 1,640).
We further excluded women with self-reported physician-
diagnosed diabetes (n ¼ 215), cardiovascular diseases
(n ¼ 153), hyperlipidemia (n ¼ 4,538), or cancer (n ¼ 328)
(Figure 1).
Assessment of parity and lactation history
At baseline in 1989 and on each biennial questionnaire,
women reported their numberofpregnancies lasting6months.
In 1997, participants completed a detailed questionnaire
on breastfeeding for each of their first 4 children, including
Nurses’ Health Study II
116,608 Exclusions at baseline 60,785
Nulliparous in 2003 22,590
Missing breastfeeding 19,605
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Figure 1. Study population, Nurses’ Health Study II, United States,
1991–2005. Participants were excluded from follow-up if they were
diagnosed with hypertension or died. Participants were skipped in the
current follow-up cycle if they were nulliparous, had unknown hy-
pertension status, or were missing information on current body
mass index. BMI, body mass index; CVD, cardiovascular disease;
HTN, hypertension.
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timing of introducing formula and solid foods. Women with
births after 1997 completed a similar questionnaire in 2003.
Measurement of the outcome
At baseline and on biennial follow-up questionnaires, par-
ticipants were asked to report whether they had ever had
a physician diagnosis of high blood pressure, excluding during
pregnancy. If so, they were asked what year they received this
diagnosis. Self-reported hypertension has been previously
validated in our population by review of medical records
for a randomly selected sample of 147 participants (19). The
sensitivity of self-reported hypertension was 94%, and the
specificity of reporting no diagnosis of hypertension was 85%.
At baseline in 1989, participants were also asked to report their
usual blood pressure when checked within the last 2 years.
Measurement of covariates
We included the following time-fixed covariates in our
covariate-adjusted models: year of first birth, body mass index
at age 18 years, family history of hypertension, self-classified
race, and history of pregnancy complications. Parental history
of hypertension and self-reported race were assessed on the
1989 questionnaire. Pregnancy complications, including ges-
tational diabetes, preeclampsia, gestational hypertension, ges-
tational diabetes, preterm birth, late miscarriage or stillbirth,
and low birth weight, were self-reported on a supplemental
questionnaire in 2001.
Time-varying covariate data were collected on multiple
questionnaires. On each questionnaire, women reported cur-
rent weight, use of nonnarcotic analgesics, and oral contra-
ceptive use. Women reported height in 1989. We used current
weight and self-reported height to calculate BMI (weight (kg)/
height (m)2) at each follow-up time. Women reported alcohol
consumption in 1991, 1995, 1999, and 2003 and physical
activity in 1989, 1991, 1997, and 1999 (20). We calculated
a Dietary Approaches to Stop Hypertension (DASH) diet score
for each participant on the basis of validated food frequency
questionnaires collected every 4 years (3).
Statistical analysis
The hazard ratio of incident hypertension by lactation his-
tory was assessed with a Cox proportional hazards model.
Women contributed person-years from 1991 until diagnosis of
hypertension, death, or study end date of June 2005. Because
lactation duration was reported categorically, we modeled our
primary analysis using categories. Two-sided P values are
reported for trends, and 95% confidence intervals are reported
for hazard ratio estimates.
As lactation is highly correlated with other health behaviors,
both residual confounding and unmeasured confounding are
major concerns. To address this problem, we used 2 different
approaches. For our primary analysis, we used propensity
scores with inverse probability weights (IPWs) to model the
association between duration of lactation for the first child
and incident hypertension. We then performed a sensitivity
analysis to determine the degree of unmeasured confounding
that would be needed to explain observed associations. In
a secondary analysis, we measured the association between
mean duration per child and incident hypertension, using
multivariable regression.
All major medical organizations in the United States rec-
ommend 6 months of exclusive and 12 months of total
breastfeeding for each child (21–23). We therefore used
these durations as referent categories. We defined optimal
breastfeeding as having occurred when a mother reported
both 12 months of total breastfeeding and 6 months of
exclusive breastfeeding for her first child.
To account for differences in other risk factors for hyperten-
sion, we created propensity scores for breastfeeding duration
categories (24, 25). We used multinomial regression to model
probability of each duration category as a function of cova-
riates at study baseline in 1991, or, for women whose first
birth occurred after 1993, at the cycle immediately preceding
her first birth. We included in this propensity score body mass
index at age 18 years and year of first birth (linear and
quadratic), self-reported history of pregnancy complications
(ever/never history of each condition: preeclampsia, gestational
hypertension, gestational diabetes, preterm birth, low birth
weight infant, or stillbirth), smoking status (current, past, miss-
ing), vigorous physical activity (<30, 30–59, 60–119, 120–209,
210 minutes/week), alcohol consumption (<1, 1–4, 5–9,
10 –14, 15–29, 30 g/day), DASH diet score quintile, fam-
ily history of hypertension, current oral contraceptive use,
current nonnarcotic analgesic use (none,<2,2 days/week),
and self-reported race (white, Hispanic, black, Asian, other).
We constructed weights for each participant using the in-
verse probability of the duration category she reported (26).
We used these normalized IPWs in our Cox proportional
hazards models. All models were adjusted for the woman’s
age and follow-up time in months. To test whether BMI was
an intermediate between lactation duration and incident hy-
pertension, we added BMI to our IPW models, using 3-knot
quadratic splines (27) to allow for nonlinear associations. We
then performed a sensitivity analysis (28, 29) to determine
the degree of unobserved confounding that would explain
observed associations.
Many of the women in our cohort gave birth prior to the
start of study follow-up in 1991, so we could not adjust for
concurrent behaviors. In an additional sensitivity analysis, we
limited our population to women with a first birth after 1989.
For propensity weights, we further included pregravid BMI,
defined as the BMI in the cycle prior to the first birth.
We further estimated the population-attributable risk of sub-
optimal lactation, which is the hypothetical proportion of
hypertension cases that would be avoided if all individuals in
the study lactated exclusively for6 months and continued for
12 months. We used a previously published statistical
approach (30) for this calculation, which assumes that there
is an independent, causal association between lactation and
incident hypertension.
To determine whether our results were sensitive to our
modeling approach, we further measured the association
between mean duration of lactation per child and incident
hypertension, using Cox proportional hazards regression. We
derived 2 variables, mean total duration per child and mean ex-
clusive duration per child, which were updated during follow-
up, as were lifestyle covariates. To test whether pregnancy
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Table 1. Age-standardizeda Characteristics of 55,636 Parous Women in the Nurses’ Health Study II During Study Follow-up, by Duration of Lactation for First Child, United States, 1991–
2005
Duration of Lactation for First Child, months
None >0–3 >3–6 >6–9 >9–<12 ‡12
No. Mean No. Mean No. Mean No. Mean No. Mean No. Mean
Person-years 126,012 95,475 125,370 111,970 89,853 112,200
Age in 1991, yearsb 37.3 35.5 35.1 35.2 35.4 35.7
Year of first birthb 1978 1982 1983 1983 1983 1983
% Mean % Mean % Mean % Mean % Mean % Mean
Race/ethnicityc
White 92.4 93.0 93.3 93.9 94.5 95.4
Black 2.0 0.9 0.9 0.9 0.6 0.4
Hispanic 0.9 1.0 1.0 0.8 0.7 0.8
Asian 0.8 1.7 1.5 1.2 1.0 1.1
Other 2.1 1.6 1.8 1.5 1.7 1.2
Missing 1.8 1.8 1.6 1.7 1.6 1.2
Body mass index at age 18 years,
kg/m2
20.7 20.9 20.6 20.5 20.5 20.5
Body mass index in follow-up
(1991–2005), kg/m2
25.1 25.3 24.9 24.6 24.4 24.2
Family history of hypertension 49.8 46.5 46.9 46.4 47.1 46.1
Parity
1 22.0 19.4 19.3 16.3 15.1 17.4
2 48.1 49.8 48.7 48.6 47.5 45.6
3 22.3 23.1 24.2 26.0 27.7 25.7
4 7.7 7.6 7.9 9.1 9.8 11.4
Any pregnancy complicationd 24.9 23.8 22.9 21.9 21.7 22.1
Ever preeclampsia 10.1 9.8 9.6 8.5 8.2 8.2
Ever gestational hypertension 6.1 6.5 6.9 6.3 6.3 6.5
Ever gestational diabetes 4.7 5.3 5.1 5.0 5.1 5.4
Ever infant <2.5 kg 5.7 4.6 3.7 3.4 3.8 3.5
Ever preterm birth 9.0 8.2 7.2 7.5 7.6 6.9
Ever stillbirth at >12 weeks 2.1 1.4 1.2 1.4 1.8 1.6
Smoking statuse
Past 24.0 23.7 24.7 24.4 22.6 22.8
Current 14.2 10.4 9.2 7.5 5.9 4.3











































Quintile 1 27.8 22.7 18.8 15.0 12.8 10.5
Quintile 2 22.1 22.1 21.6 19.4 18.0 15.6
Quintile 3 17.8 17.9 18.7 19.2 19.1 17.6
Quintile 4 14.9 17.5 19.7 21.0 22.1 23.0
Quintile 5 10.6 13.5 15.7 19.5 22.9 28.3
Alcohol consumption, g/daye
<1 37.6 35.4 31.7 31.6 34.9 38.6
1–4 31.8 32.3 33.6 33.1 32.1 31.0
5–9 8.6 9.2 10.1 10.6 10.0 9.3
10–14 4.4 4.6 5.7 5.9 5.5 5.0
15–29 2.3 2.6 3.2 3.5 3.2 2.9
30 0.9 1.0 1.3 1.2 1.2 1.0
Vigorous exercise, minutes/weeke
<30 42.3 43.6 40.0 38.9 37.7 38.1
30–59 11.0 10.4 10.8 10.6 11.1 10.6
60–119 17.3 16.5 17.3 17.8 17.8 18.3
120–209 10.6 10.6 11.3 11.5 12.6 12.6
210 7.8 7.9 9.3 10.3 10.5 10.5
Any analgesic at least 1 time/week 44.5 45.7 47.2 49.1 49.4 53.5
Abbreviation: DASH, Dietary Approaches to Stop Hypertension.
a Data are presented as percentages unless otherwise indicated and are directly standardized in years to the age distribution of the Nurses’ Health Study II.
b Unadjusted mean age in 1991 and year of first birth.
c Total sums to >100 because participants could select more than one race/ethnicity.
d Any pregnancy complicated by preeclampsia, gestational hypertension, gestational diabetes, birth of an infant at<37 weeks’ gestation, birth of an infant weighing<2,500 g, or miscarriage
or stillbirth at >12 weeks’ gestation.































































complications confounded the association between lactation
duration and incident hypertension, we quantified changes
in parameter estimates for each duration category in age-
adjusted models and in models adjusting for each pregnancy
complication. To test whether a history of gestational hyper-
tension, preeclampsia, or both modified associations between
lactation and incident hypertension, we tested for effect
modification using an interaction term.
All analyses were performed by using SAS, version 9.1,
software (SAS Institute, Inc., Cary, North Carolina). The
Institutional Review Board of Partners Healthcare approved
the study. All P values were 2 tailed, and values of less than
0.05 were considered statistically significant.
RESULTS
There were 55,636 parous women who were eligible for
our analysis, of whom 80.6% had breastfed their first child,
16.8% had breastfed their first child for 12 months, and
14.6% had exclusively breastfed their first child for6months.
Longer lactation duration for the first child was associated
with higher parity (Table 1), as well as lower BMI during
follow-up, less family history of hypertension, less fre-
quent smoking, and oral contractive use, higher DASH diet
score, more frequent vigorous exercise, and more analgesic
use.
Both total duration and exclusive duration of lactation for
the first child were correlated with subsequent parity (Mantel-
Haenszel chi-square test for trend, P< 0.0001), and lactation
durations among siblings were highly correlated (Pearson’s
r¼ 0.46–0.81) (P< 0.0001). Thus, paritymay be a ‘‘collider,’’
and adjustment for parity may produce false associations
between lactation duration and outcome (31). For our pri-
mary analysis, we therefore analyzed the association between
lactation duration for the first child (not all children) and
incident hypertension.
We ascertained 8,861 cases of incident hypertension during
660,880 person-years of follow-up. We found a dose-response
association between never or curtailed breastfeeding and in-
cident hypertension risk. In IPW-adjusted models, mothers
who had never breastfed had a 1.27-fold risk of incident
hypertension (95% confidence interval (CI): 1.18, 1.36) (across
breastfeeding duration categories, Ptrend < 0.001) compared
with mothers who lactated for12months after their first birth
(Figure 2; Table 2). To test whether BMI mediated this asso-
ciation, we further adjusted for BMI during follow-up, which
modestly attenuated the association (for never vs.12 months
of lactation for the first child, BMI-adjusted hazard ratio
(HR) ¼ 1.22, 95% CI: 1.13, 1.31) (across breastfeeding
duration categories, Ptrend < 0.001). When we measured the
association between duration of exclusive lactation and in-
cident hypertension, we found that women who did not lactate
had an IPW-adjusted 1.29-fold risk of incident hypertension
(95% CI: 1.20, 1.40) (across breastfeeding duration categories,
Ptrend < 0.001) compared with having exclusively lactated
for 6 months after the first birth (Table 2). Again, this asso-
ciation was somewhat attenuated in models adjusting for
BMI during follow-up (for never vs. 6 months of exclu-
sive lactation for the first child, BMI-adjusted HR ¼ 1.22,
95%CI: 1.13, 1.31) (across breastfeeding duration categories,
Ptrend < 0.001). All associations were materially unchanged
with adjustment for lifetime parity.
We then considered the degree of unobserved confounding
that would explain our results. Assuming an unobserved binary
confounding factor perfectly correlated with lactation in the
longest duration category, we found that unmeasured con-
founders with effect sizes of 0.85 for12 months’ total and
0.83 for 6 months’ exclusive lactation for the first child
would be needed to explain the observed difference in in-
cident hypertension among women in these groups versus
those who had never breastfed. These effect sizes are similar
in magnitude to the associations between 7 days/week of
vigorous physical activity versus <1 day/week of vigorous
activity (HR¼ 0.87, 95%CI: 0.81, 0.93) or a DASH diet score
Figure 2. Association between duration of total breastfeeding for the
first child and incident hypertension among 55,636 parous women in
the Nurses’ Health Study II, United States, 1991–2005. Adjusted for
age and inverse probability weight, derived from a multinomial logistic
regression model for probability of each breastfeeding duration cate-
gory as a function of maternal body mass index at age 18 years (linear
and quadratic), year of first birth (linear and quadratic), self-reported
history of preeclampsia, gestational hypertension, gestational diabetes,
birth of an infant at <37 weeks’ gestation, birth of an infant weighing
<2,500 g, miscarriage or stillbirth at>12 weeks’ gestation, smoking
status, vigorous physical activity, alcohol consumption, Dietary Ap-
proaches to Stop Hypertension (DASH) diet score quintile, family history
of hypertension, current oral contraceptive use, current nonnarcotic
analgesic use, and self-reported race.
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in the highest versus lowest quintile (HR¼ 0.82, 95%CI: 0.77,
0.87) in prior studies (3).
To determine whether measuring health behaviors at the
time of the first birth affected our results, we limited our
population to 8,318 women with a first birth after 1989.
In IPW-adjusted models, we found a hazard ratio ¼ 1.31
(95% CI: 1.00, 1.71) for women who never lactated and 1.40
(95%CI: 1.07, 1.82) for womenwho lactated for>0–3months
compared with women who lactated for 12 months. Ad-
justment for BMI during follow-upmodestly attenuated these
associations (never vs.12 months, HR¼ 1.22, 95%CI: 0.93,
1.60;>0–3 vs.12 months, HR¼ 1.22, 95% CI: 0.93, 1.59).
We then estimated the population-attributable risk due
to suboptimal lactation, defined as <6 months’ exclusive
lactation and/or <12 months’ total lactation, and incident
hypertension. If this association is causal, we estimate that
12% (95% CI: 4.9, 19) of incident hypertension in our pop-
ulation could be attributed to suboptimal lactation.
In a secondary analysis, we measured the association be-
tween mean lactation duration per child and incident hyper-
tension in the full study cohort (Table 3). With adjustment
for lifestyle covariates and hypertension risk factors, we found
a 1.22-fold risk (95% CI: 1.13, 1.32) (across breastfeeding
duration categories, Ptrend < 0.001), comparing women who
had never breastfed versus those who lactated 12 months
per child. Curtailed lactation was also associated with in-
creased risk: compared with 12 months per child, women
with >0 –3 or >3–<6 months per child had a 1.21-fold
(95% CI: 1.12, 1.30) and a 1.19-fold (95% CI: 1.11, 1.28)
increased risk of incident hypertension in covariate-adjusted
models. We similarly found an increased risk of incident hy-
pertension with never or curtailed exclusive lactation (Table 3).
With adjustment for covariates, we found a 1.16-fold risk
(95% CI: 1.05, 1.27) (across breastfeeding duration categories,
Ptrend < 0.001) for women who had never breastfed com-
pared with a mean exclusive duration of 6 months or more.
These results were materially unchanged with adjustment
for current BMI and parity.
We found that adjustment for ever-history of preeclampsia
slightly attenuated associations between lactation duration
and incident hypertension. Our results were materially un-
changed with adjustment for other pregnancy complications.
We found no evidence for an interaction between ever-
history of gestational hypertension or preeclampsia, lactation
Table 2. Association Between Duration of Breastfeeding for the First Child and Incident Hypertension Among 55,636 Parous Women in the



















Never 2,179 126,012 1.46 1.36, 1.57 1.27 1.18, 1.36 1.22 1.13, 1.31
>0–3 months 1,459 95,475 1.46 1.35, 1.57 1.29 1.20, 1.39 1.24 1.15, 1.33
>3–<6 months 1,639 125,370 1.28 1.19, 1.38 1.16 1.08, 1.25 1.13 1.05, 1.22
6–<9 months 1,356 111,970 1.17 1.08, 1.26 1.11 1.03, 1.19 1.09 1.01, 1.17
9–<12 months 1,014 89,853 1.07 0.99, 1.17 1.03 0.95, 1.11 1.03 0.96, 1.11
12 months 1,214 112,200 1.00 Referent 1.00 Referent 1.00 Referent
Ptrend <0.001 <0.001 <0.001
Exclusive breastfeeding
Never breastfed 2,179 126,012 1.45 1.34, 1.56 1.29 1.20, 1.39 1.22 1.13, 1.31
Breastfed, never
exclusively
2,801 198,791 1.32 1.23, 1.42 1.11 1.03, 1.19 1.07 1.00, 1.15
>0–3 months
exclusively
1,491 118,373 1.19 1.10, 1.29 1.08 0.99, 1.18 1.08 0.99, 1.18
>3–<6 months
exclusively
1,319 118,717 1.08 1.00, 1.17 1.03 0.95, 1.12 1.04 0.96, 1.13
6 months
exclusively
1,054 97,390 1.00 Referent 1.00 Referent 1.00 Referent
Ptrend <0.001 <0.001 <0.001
Abbreviations: BMI, bodymass index; CI, confidence interval; DASH, Dietary Approaches to Stop Hypertension; IPW, inverse probability weight.
a Inverse probability weight-adjusted Cox proportional hazards regression models were used.
b Adjusted for participant’s age and follow-up time in months.
c Inverse probability weights derived from multinomial logistic regression model for probability of each breastfeeding duration category as
a function of maternal BMI at age 18 years (linear and quadratic), year of first birth (linear and quadratic), self-reported history of preeclampsia,
gestational hypertension, gestational diabetes, birth of an infant at <37 weeks’ gestation, birth of an infant weighing <2,500 g, miscarriage or
stillbirth at >12 weeks’ gestation, smoking status, vigorous physical activity, alcohol consumption, DASH diet score quintile, family history of
hypertension, current oral contraceptive use, current nonnarcotic analgesic use, and self-reported race.
d BMI during follow-up modeled by using a 3-knot quadratic spline.
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Never breastfed 1,522 89,026 1.48 1.38, 1.60 1.22 1.13, 1.32 1.20 1.10, 1.29 1.16 1.07, 1.26
>0–3 months 1,893 127,191 1.43 1.33, 1.54 1.21 1.12, 1.30 1.14 1.06, 1.23 1.13 1.05, 1.22
>3–<6 months 1,930 143,362 1.32 1.23, 1.42 1.19 1.11, 1.28 1.14 1.06, 1.22 1.13 1.05, 1.21
6–<9 months 1,525 125,810 1.17 1.08, 1.26 1.09 1.02, 1.18 1.07 0.99, 1.15 1.07 0.99, 1.15
9–<12 months 1,049 87,155 1.14 1.05, 1.24 1.07 0.99, 1.17 1.07 0.99, 1.16 1.08 0.99, 1.17
12 months 1,282 119,499 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
Ptrend <0.001 <0.001 <0.001 <0.001
Mean exclusive
duration/child
Never breastfed 1,522 89,026 1.45 1.32, 1.58 1.16 1.05, 1.27 1.14 1.04, 1.26 1.12 1.02, 1.23
Breastfed, never
exclusively
2,337 162,909 1.34 1.23, 1.46 1.14 1.04, 1.24 1.10 1.01, 1.20 1.09 1.00, 1.19
>0–3 months 2,288 172,266 1.24 1.13, 1.35 1.08 0.99, 1.18 1.06 0.97, 1.15 1.07 0.98, 1.16
>3–<6 months 1,914 164,355 1.10 1.01, 1.20 1.04 0.95, 1.13 1.03 0.95, 1.13 1.04 0.95, 1.13
6 months 707 65,167 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
Ptrend <0.001 <0.001 0.001 0.01
Abbreviations: BMI, body mass index; CI, confidence interval; DASH, Dietary Approaches to Stop Hypertension.
a Multivariable Cox proportional hazards regression models were used.
b Adjusted for participant’s age and follow-up time in months.
c Covariate-adjusted models include maternal BMI at age 18 years (linear and quadratic), year of first birth (linear and quadratic), self-reported history of preeclampsia, gestational
hypertension, gestational diabetes, birth of an infant at <37 weeks’ gestation, birth of an infant weighing <2,500 g, miscarriage or stillbirth at >12 weeks’ gestation, smoking status, vigorous
physical activity, alcohol consumption, DASH diet score quintile, family history of hypertension, current oral contraceptive use, current nonnarcotic analgesic use, and self-reported race.










































duration, and incident hypertension (for log likelihood ratio
test, all P > 0.15).
DISCUSSION
We found a direct association between never or curtailed
lactation and incident hypertension in a large, prospec-
tive cohort of parous women. We found an increased risk
of hypertension among women who breastfed each child
for <9 months compared with women who breastfed each
child for 12 months, as well as among women who never
breastfed exclusively, compared with women who breastfed
exclusively for6 months per child. This association persisted
after adjustment for multiple hypertension risk factors by
using 2 modeling approaches. In addition, we quantified the
degree of unmeasured confounding that would explain ob-
served associations. Our results strengthen the evidence for
a causal association between never or curtailed breastfeeding
and maternal hypertension.
Our findings confirm and extend earlier work linking lac-
tation with blood pressure regulation. Light et al. (32) reported
higher maternal blood pressure among formula-feeding
mothers versus lactating mothers after infant feeding. Others
have described increased autonomic and hypothalamic-
pituitary-adrenal axis stress response to stressors among
formula-feeding versus breastfeeding women (33, 34).
Authors have also previously reported differences in hy-
pertension associated with lifetime lactation (Table 4). Lee
et al. (4) assessed incident hypertension among 177,749 parous
women in the Korean Women’s Cohort Study and found
the lowest risk among women with 1–6 months of lifetime
lactation (vs. never having lactated, relative risk ¼ 0.90,
95% CI: 0.87, 0.93). Lactation duration was associated with
lower hypertension prevalence among women in the Study
of Women’s Health Across the Nation (SWAN) (n ¼ 2,516)
(per year of lifetime lactation, odds ratio¼ 0.90, 95%CI: 0.81,
0.996) (11). Schwarz et al. (5) assessed prevalent hyperten-
sion in the Women’s Health Initiative (n ¼ 139,681) and
found a dose-dependent inverse association (for24 months’
lactation vs. never, odds ratio ¼ 0.87, 95% CI: 0.82, 0.93)
(Ptrend < 0.001). This association persisted with adjustment
for maternal BMI.
We similarly found that adjustment for BMI did not fully
explain associations between curtailed lactation and hyper-
tension risk. We speculate that differences may be mediated,
in part, by the neuropeptide oxytocin, working centrally and/or
peripherally. Oxytocin is released during lactation to facilitate
milk let-down, and converging evidence supports a regulatory
role for oxytocin on autonomic cardiac control. Animal studies
show that oxytocin administration causes changes in blood
pressure regulation that persist for at least 3 weeks after
discontinuation (15). Moreover, central oxytocinergic fibers
inhibit sympathetic and promote parasympathetic activity to
the heart (35, 36). In the periphery, oxytocin binding to cardiac
and vascular endothelial receptors reduces the heart rate and
enhances vasodilation (37, 38). Postpartum oxytocin levels are
associated with reduced stress-induced vasoconstriction and
norepinephrine, a biomarker of sympathetic activation (39).
We speculate that lactation leads to changes in central oxytocin
release and/or peripheral receptor expression that persist
after weaning, thereby diminishing blood pressure in later
life. Prolactin may also play a role. Zhang et al. (16) recently
reported a direct association between serum prolactin and
incident hypertension in the Nurses’ Health Study. Never
breastfeeding was associated with higher prolactin in 1 pro-
spective cohort study (40), although not in the Nurses’ Health
Study cohort (41).
Our findings must be interpreted in the context of the study
design. Both obesity and insulin resistance are associated
with lactation difficulties, suggesting that curtailed lactation
could be a marker for metabolic risk (42, 43). These asso-
ciations may explain the slightly higher risk of incident hy-
pertension among women with>0–3 months of lactation for
their first child compared with those who never breastfed.
Moreover, pregnancy complications, such as preeclampsia
or preterm birth, may interfere with lactation, and these
conditions are risk factors for later cardiovascular disease.
A key strength of our study was our inclusion of BMI at age
18 years and pregnancy complications in our adjusted models.
Our results do not support our hypothesis that pregnancy
complications confound associations between breastfeeding
and maternal health. Nevertheless, we cannot exclude the pos-
sibility that optimal lactation duration may be a marker for
health, rather than a mechanism to prevent subsequent disease.
Unmeasured confounders are another concern. A woman
whose circumstances allow optimal lactation may experience
less chronic stress and thus face a lower risk of hyperten-
sion (44). However, when we performed a sensitivity analysis,
we found that our results were robust. We found that un-
measured confounders would have to be as strongly associated
with hypertension as 30 minutes per day of vigorous physical
activity versus no physical activity or DASH diet score in the
highest versus lowest quintile to explain our findings.
Of note, all participants in our study are registered nurses,
and 94% are Caucasian, so confounding by race or socio-
economic status is less likely than in a more diverse cohort.
Nevertheless, if the choice of nursing as an occupation is
correlated with unobserved determinants of health, then
conditioning on occupation could affect observed associ-
ations (45). In this case, nursing as an occupation would serve
as a collider, potentially biasing our results.
Missing data are another concern. We found that women
missing data on breastfeeding were more likely to be non-
white, to be smokers, and to be missing other health behavior
data, suggesting that women who were included in our anal-
ysis may be more health conscious, potentially biasing our
results. Finally, misclassification is also a potential concern.
Promislow et al. (46) compared recalled lactation with pro-
spective menstrual diaries and found overall correlation of
0.55, with a mean difference between recorded and recalled
duration of 0 (standard deviation, 2.7) months, indicating
no overall recall bias. If such misclassification occurred in
our cohort, it would likely bias our results toward the null;
thus, our observed association may underestimate the true
association.
In conclusion, we found that never or curtailed lactation is
associated with increased incident hypertension among parous
women, independent of BMI. If this association is causal,
12% of incident hypertension cases among parous women
can be attributed to suboptimal breastfeeding. Policies that
Lactation and Incident Maternal Hypertension 1155
Am J Epidemiol. 2011;174(10):1147–1158



















Lee, 2005 (4) Premenopausal Korean women, >20 years, without
prevalent hypertension at baseline
Incident documented
hypertension
(SBP >140, DBP >90,
or antihypertensive
medications)
0.92 0.90, 0.96 Lifetime vs. never
Age, obesity, smoking, alcohol drinking, exercise,
number of children, and age at first pregnancy
Never 1.00 Referent
1–6 months 0.90 0.87, 0.93
7–12 months 0.92 0.87, 0.98
13–18 months 0.93 0.86, 0.99
19–24 months 1.00 0.91, 1.11
>24 months 1.06 0.99, 1.14






SBP >140, DBP >90)
Not reported Lifetime vs. never
Age; race; parity; age at menopause; education;
income; family history of diabetes mellitus,
myocardial infarction, or stroke; tobacco history;
current physical activity; energy, cholesterol, fat,
fiber, and sodium intakes; hormone therapy;
aspirin; and multivitamin use
Never 1.00 Referent
1–6 months 0.95 0.92, 0.98
7–12 months 0.88 0.84, 0.91
13–23 months 0.89 0.84, 0.93
24 months 0.87 0.82, 0.93
Ptrend <0.001
Ram, 2008 (11) Premenopausal US women aged 42–52 years,
with an intact uterus, 1 ovary, no use of







0.83 0.68, 0.998 Per year lifetime 0.90 0.81, 0.996
Age, smoking history, parity, ethnicity, study site,
socioeconomic status, high school BMI, current
physical activity, and daily caloric intake
Stuebe, 2011
(current study)
Parous US women aged 27–44 years without
prevalent hypertension, diabetes, cardiovascular
disease, hyperlipidemia, or cancer in 1991
Incident self-reported
hypertension
Not reported Duration first
child vs.
12 months
Maternal BMI at age 18 years, year of first birth,
self-reported history of preeclampsia, gestational
hypertension, gestational diabetes, birth of an
infant at <37 weeks’ gestation, birth of an infant
weighing <2,500 g, miscarriage or stillbirth at
>12 weeks’ gestation, smoking status, vigorous
physical activity, alcohol consumption, DASH
diet score quintile, family history of hypertension,
current oral contraceptive use, current
nonnarcotic analgesic use, and self-reported race
Never 1.27 1.18, 1.36
>0–3 months 1.29 1.20, 1.39
>3–<6 months 1.16 1.08, 1.25
6–<9 months 1.11 1.03, 1.19
9–<12 months 1.03 0.95, 1.11
12 months 1.00 Referent
Abbreviations: BMI, body mass index; CI, confidence interval; DASH, Dietary Approaches to Stop Hypertension; DBP, diastolic blood pressure; SBP, systolic blood pressure.










































increase support for breastfeeding mothers (47) may decrease
the burden of hypertensive disease among parous women.
ACKNOWLEDGMENTS
Author affiliations: Department of Obstetrics and Gyne-
cology, School of Medicine, University of North Carolina,
Chapel Hill, North Carolina (Alison M. Stuebe); Department
of Psychiatry, School of Medicine, University of North
Carolina, Chapel Hill, North Carolina (Karen Grewen); De-
partment of Maternal-Child Health, Gillings Global School
of Public Health, University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina (Alison M. Stuebe, E. Michael
Foster); Department of Health Policy and Administration,
Gillings Global School of Public Health, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina
(E. Michael Foster); Department of Medicine, Center
for Research on Health Care, University of Pittsburgh,
Pittsburgh, Pennsylvania (Eleanor B. Schwarz); Depart-
ment of Epidemiology, Center for Research on Health Care,
University of Pittsburgh, Pittsburgh, Pennsylvania (Eleanor
B. Schwarz); Department of Obstetrics, Gynecology, and
Reproductive Sciences, Center for Research on Health
Care, University of Pittsburgh, Pittsburgh, Pennsylvania
(Eleanor B. Schwarz); Department of Epidemiology,
Harvard School of Public Health, Boston, Massachusetts
(Janet W. Rich-Edwards, Karen B. Michels, Gary Curhan);
Department of Nutrition, Harvard School of Public Health,
Boston, Massachusetts (Karen B. Michels); Division of
Women’s Health, Brigham and Women’s Hospital,
Harvard Medical School, Boston, Massachusetts (Janet
W. Rich-Edwards); Department of Obstetrics, Gynecology,
and Reproductive Biology, Obstetrics and Gynecology
Epidemiology Center, Harvard Medical School, Boston,
Massachusetts (Karin B. Michels); and Renal Division and
Channing Laboratory, Department of Medicine, Brigham
and Women’s Hospital, Harvard Medical School, Boston,
Massachusetts (Gary Curhan, John Forman).
This study was funded by the American Heart Association
(grant 0535401T) and by the National Institutes of Health
(grants HL079929-01A2, CA50385, and 5K12HD050113-04
to A. M. S.).
The authors thank Eileen Hibert for technical support.
Preliminary findings were presented at the 57th Annual
Meeting of the Society for Gynecological Investigation,
Orlando, Florida, March 24–27, 2010.
Dr. Foster has received grant support from the Mead
Johnson Center for Clinical Excellence. The other authors
have no conflicts of interest to disclose.
REFERENCES
1. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness,
treatment, and control of hypertension among United States
adults 1999–2004. Hypertension. 2007;49(1):69–75.
2. Lowe LP, Greenland P, Ruth KJ, et al. Impact of major car-
diovascular disease risk factors, particularly in combination,
on 22-year mortality in women and men. Arch Intern Med.
1998;158(18):2007–2014.
3. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk
factors associated with incident hypertension in women.
JAMA. 2009;302(4):401–411.
4. Lee SY, Kim MT, Jee SH, et al. Does long-term lactation
protect premenopausal women against hypertension risk?
A Korean women’s cohort study. Prev Med. 2005;41(2):
433–438.
5. Schwarz EB, Ray RM, Stuebe AM, et al. Duration of lactation
and risk factors for maternal cardiovascular disease. Obstet
Gynecol. 2009;113(5):974–982.
6. Stuebe AM, Rich-Edwards JW, Willett WC, et al. Duration
of lactation and incidence of type 2 diabetes. JAMA. 2005;
294(20):2601–2610.
7. Villegas R, Gao YT, Yang G, et al. Duration of breast-feeding
and the incidence of type 2 diabetes mellitus in the Shanghai
Women’s Health Study. Diabetologia. 2008;51(2):258–266.
8. Schwarz EB, Brown JS, Creasman JM, et al. Lactation and
maternal risk of type 2 diabetes: a population-based study.
Am J Med. 2010;123(9):863.e1–863.e6.
9. Gunderson EP, Lewis CE, Wei GS, et al. Lactation and
changes in maternal metabolic risk factors. Obstet Gynecol.
2007;109(3):729–738.
10. Gunderson EP, Jacobs DR Jr, Chiang V, et al. Duration of
lactation and incidence of the metabolic syndrome in women
of reproductive age according to gestational diabetes mellitus
status: a 20-year prospective study in CARDIA (Coronary
Artery Risk Development in Young Adults). Diabetes. 2010;
59(2):495–504.
11. Ram KT, Bobby P, Hailpern SM, et al. Duration of lactation
is associated with lower prevalence of the metabolic syndrome
in midlife—SWAN, the Study of Women’s health Across the
Nation. Am J Obstet Gynecol. 2008;198(3):268.e1–268.e6.
12. Stuebe AM, Michels KB, Willett WC, et al. Duration of
lactation and incidence of myocardial infarction in middle
to late adulthood. Am J Obstet Gynecol. 2009;200(2):
138.e1–138.e8.
13. Schwarz EB, McClure CK, Tepper PG, et al. Lactation and
maternal measures of subclinical cardiovascular disease.
Obstet Gynecol. 2010;115(1):41–48.
14. Stuebe AM, Rich-Edwards JW. The reset hypothesis: lactation
and maternal metabolism. Am J Perinatol. 2009;26(1):81–88.
15. Petersson M, Alster P, Lundeberg T, et al. Oxytocin causes
a long-term decrease of blood pressure in female and male
rats. Physiol Behav. 1996;60(5):1311–1315.
16. Zhang L, Curhan GC, Forman JP. Plasma prolactin level and
risk of incident hypertension in postmenopausal women.
J Hypertens. 2010;28(7):1400–1405.
17. Beck LF, Morrow B, Lipscomb LE, et al. Prevalence of selected
maternal behaviors and experiences, Pregnancy Risk Assessment
Monitoring System (PRAMS), 1999. MMWR Surveill Summ.
2002;51(2):1–27.
18. Pesa JA, Shelton MM. Health-enhancing behaviors correlated
with breastfeeding among a national sample of mothers.
Public Health Nurs. 1999;16(2):120–124.
19. Forman JP, CurhanGC, Taylor EN. Plasma 25-hydroxyvitaminD
levels and risk of incident hypertension among young women.
Hypertension. 2008;52(5):828–832.
20. Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and
validity of a self-administered physical activity questionnaire.
Int J Epidemiol. 1994;23(5):991–999.
21. Gartner LM, Morton J, Lawrence RA, et al. Breastfeeding and
the use of human milk. American Academy of Pediatrics
Section on Breastfeeding. Pediatrics. 2005;115(2):496–506.
Lactation and Incident Maternal Hypertension 1157
Am J Epidemiol. 2011;174(10):1147–1158
22. American College of Obstetricians and Gynecologists.
Breastfeeding: maternal and infant aspects. Special report
from ACOG. ACOG Clin Rev. 2007;12(suppl 1):1S–16S.
23. Breastfeeding (position paper). Shawnee Mission, KS: American
Academy of Family Physicians; 2001. (http://www.aafp.org/
online/en/home/policy/policies/b/breastfeedingpositionpaper.
html) (Accessed June 10, 2009).
24. Foster EM. Is more treatment better than less? An application of
propensity score analysis. Med Care. 2003;41(10):1183–1192.
25. Imbens GW. The Role of the Propensity Score in Estimating
Dose-Response Functions. Cambridge, MA: National Bureau
of Economic Research; 1999.
26. Robins JM. Association, causation, and marginal structural
models. Synthese. 1999;121(1):151–179.
27. Greenland S. Dose-response and trend analysis in epidemiol-
ogy: alternatives to categorical analysis. Epidemiology.
1995;6(4):356–365.
28. Rosenbaum P. Observational Studies. 2nd ed. New York, NY:
Springer; 2002.
29. Rosenbaum PR. Design of Observational Studies. 1st ed.
New York, NY: Springer; 2009.
30. Spiegelman D, Hertzmark E, Wand HC. Point and interval
estimates of partial population attributable risks in cohort
studies: examples and software. Cancer Causes Control. 2007;
18(5):571–579.
31. Greenland S. Quantifying biases in causal models: classical
confounding vs collider-stratification bias. Epidemiology.
2003;14(3):300–306.
32. Light KC, Smith TE, Johns JM, et al. Oxytocin responsivity in
mothers of infants: a preliminary study of relationships with
blood pressure during laboratory stress and normal ambulatory
activity. Health Psychol. 2000;19(6):560–567.
33. Amico JA, Johnston JM, Vagnucci AH. Suckling-induced
attenuation of plasma cortisol concentrations in postpartum
lactating women. Endocr Res. 1994;20(1):79–87.
34. Heinrichs M, Meinlschmidt G, Neumann I, et al. Effects of
suckling on hypothalamic-pituitary-adrenal axis responses to
psychosocial stress in postpartum lactating women. J Clin
Endocrinol Metab. 2001;86(10):4798–4804.
35. Jankowski M, Wang D, Hajjar F, et al. Oxytocin and its receptors
are synthesized in the rat vasculature. Proc Natl Acad Sci
U S A. 2000;97(11):6207–6211.
36. Gutkowska J, Jankowski M, Mukaddam-Daher S, et al.
Oxytocin is a cardiovascular hormone. Braz J Med Biol Res.
2000;33(6):625–633.
37. Szeto A, Nation DA, Mendez AJ, et al. Oxytocin attenuates
NADPH-dependent superoxide activity and IL-6 secretion in
macrophages and vascular cells. Am J Physiol Endocrinol
Metab. 2008;295(6):E1495–E1501.
38. Thibonnier M, Conarty DM, Preston JA, et al. Human vascular
endothelial cells express oxytocin receptors. Endocrinology.
1999;140(3):1301–1309.
39. Grewen KM, Light KC. Plasma oxytocin is related to lower
cardiovascular and sympathetic reactivity to stress. Biol
Psychol. 2011;87(3):340–349.
40. Wang DY, de Stavola BL, Bulbrook RD, et al. The relationship
between blood prolactin levels and risk of breast cancer in
premenopausal women. Eur J Cancer Clin Oncol. 1987;23(10):
1541–1548.
41. Eliassen AH, Tworoger SS, Hankinson SE. Reproductive
factors and family history of breast cancer in relation to plasma
prolactin levels in premenopausal and postmenopausal
women. Int J Cancer. 2007;120(7):1536–1541.
42. Rasmussen KM, Hilson JA, Kjolhede CL. Obesity may
impair lactogenesis II. J Nutr. 2001;131(11 suppl):
3009S–3011S.
43. Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and
pregnancy outcome: a study of 287,213 pregnancies in
London. Int J Obes Relat Metab Disord. 2001;25(8):
1175–1182.
44. Steptoe A, Willemsen G. The influence of low job control
on ambulatory blood pressure and perceived stress over the
working day in men and women from the Whitehall II cohort.
J Hypertens. 2004;22(5):915–920.
45. Hernán MA, Hernández-Dı́az S, Robins JM. A structural
approach to selection bias. Epidemiology. 2004;15(5):
615–625.
46. Promislow JH, Gladen BC, Sandler DP. Maternal recall of
breastfeeding duration by elderly women. Am J Epidemiol.
2005;161(3):289–296.
47. US Department of Health and Human Services. The Surgeon
General’s Call to Action to Support Breastfeeding.
Washington, DC: Office of the Surgeon General, US Depart-
ment of Health and Human Services; 2011.
1158 Stuebe et al.
Am J Epidemiol. 2011;174(10):1147–1158
